There has been limited exploration of the relationship between ADHD and vision impairment, especially in relation to ADHD medication regimens and age. This study aims to examine trends in visual disorders in young patients with ADHD.
Methods:
We analyzed deidentified patient records from TriNetX database. Patients under 22 years old were divided into cohorts based on ADHD status and medication regimen. We compared prevalence of vision disorders between cohorts.
Results:
We studied over 1 million patients. The ADHD cohort had higher rates of all visual disorders than their non-ADHD peers. Medication usage was found to have a slight impact, with non-stimulants associating with higher rates for all outcomes.
Discussion:
Our findings suggest that the higher occurrence of visual disorders in ADHD is not primarily due to misdiagnosis or medication effects. There is a need for regular eye care in ADHD patients and further investigation into the role of ADHD medications in eye health.
BanaschewskiT.RoessnerV.DittmannR. W.SantoshP. J.RothenbergerA. (2004). Non-stimulant medications in the treatment of ADHD. European Child and Adolescent Psychiatry, Supplement, 13(1), i102–i116. https://doi.org/10.1007/S00787-004-1010-X/METRICS
2.
BellatoA.PernaJ.GanapathyP. S.SolmiM.ZampieriA.CorteseS.FaraoneS. V. (2022). Association between ADHD and vision problems. A systematic review and meta-analysis. Molecular Psychiatry, 28(1), 410–422. https://doi.org/10.1038/s41380-022-01699-0
3.
BorstingE.RouseM.ChuR. (2005). Measuring ADHD behaviors in children with symptomatic accommodative dysfunction or convergence insufficiency: A preliminary study. Optometry, 76(10), 588–592. https://doi.org/10.1016/J.OPTM.2005.07.007
4.
ChenM. H.PanT. L.HsuJ. W.HuangK. L.SuT. P.LiC. T.LinW. C.TsaiS. J.ChangW. H.ChenT. J.BaiY. M. (2018). Risk of type 2 diabetes in adolescents and young adults with attention-deficit/hyperactivity disorder: A nationwide longitudinal study. The Journal of Clinical Psychiatry, 79(3), 17m11607. https://doi.org/10.4088/JCP.17M11607
5.
ChenM. H.SuT. P.ChenY. S.HsuJ. W.HuangK. L.ChangW. H.ChenT. J.BaiY. M. (2017). Comorbidity of allergic and autoimmune diseases among patients with ADHD. Journal of Attention Disorders, 21(3), 219–227. https://doi.org/10.1177/1087054712474686
6.
ChenQ.HartmanC. A.HaavikJ.HarroJ.KlungsøyrK.HegvikT. A.WandersR.OttosenC.DalsgaardS.FaraoneS. V.LarssonH. (2018). Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study. PLoS One, 13(9), e0204516. https://doi.org/10.1371/journal.pone.0204516
7.
DecarloD. K.BowmanE.MonroeC.KlineR.McGwinG.OwsleyC. (2014). Prevalence of attention-deficit/hyperactivity disorder among children with vision impairment. Journal of AAPOS : The Official Publication of the American Association for Pediatric Ophthalmology and Strabismus, 18(1), 10–14. https://doi.org/10.1016/J.JAAPOS.2013.10.013
8.
EvansS. I.HaleE. W.SilvermanM. S. (2022). Mechanisms of bodily harm in emergency department youths with ADHD. Frontiers in Child and Adolescent Psychiatry, 1, 5. https://doi.org/10.3389/FRCHA.2022.1033822
9.
GroenmanA. P.JanssenT. W. P.OosterlaanJ. (2017). Childhood psychiatric disorders as risk factor for subsequent substance abuse: A meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 56(7), 556–569. https://doi.org/10.1016/j.jaac.2017.05.004
10.
GuvenmezO.CubukM.GunesS. (2020). The effects of medication on intraocular pressure in children with attention deficit hyperactivity disorder: A prospective study. Journal of Population Therapeutics and Clinical Pharmacology = Journal de La Therapeutique Des Populations et de La Pharmacologie Clinique, 27(2), e56–e61. https://doi.org/10.15586/JPTCP.V27I2.665
11.
HoJ. D.SheuJ. J.KaoY. W.ShiaB. C.LinH. C. (2019). Associations between attention-deficit/hyperactivity disorder and ocular abnormalities in children: A population-based study. Ophthalmic Epidemiology, 27(3), 194–199. https://doi.org/10.1080/09286586.2019.1704795
12.
KapellenT. M.ReimannR.KiessW.KostevK. (2016). Prevalence of medically treated children with ADHD and type 1 diabetes in Germany – analysis of two representative databases. Journal of Pediatric Endocrinology and Metabolism, 29(11), 1293–1297. https://doi.org/10.1515/JPEM-2016-0171
13.
LeeS. S.HumphreysK. L.FloryK.LiuR.GlassK. (2011). Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: A meta-analytic review. Clinical Psychology Review, 31(3), 328–341. https://doi.org/10.1016/J.CPR.2011.01.006
14.
MowlemF. D.RosenqvistM. A.MartinJ.LichtensteinP.AshersonP.LarssonH. (2019). Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment. European Child & Adolescent Psychiatry, 28(4), 481–489. https://doi.org/10.1007/S00787-018-1211-3
15.
Ruiz-GoikoetxeaM.CorteseS.Aznarez-SanadoM.MagallónS.Alvarez ZalloN.LuisE. O.de Castro-ManglanoP.SoutulloC.ArrondoG. (2018). Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 84, 63–71. https://doi.org/10.1016/J.NEUBIOREV.2017.11.007
16.
SayalK.PrasadV.DaleyD.FordT.CoghillD. (2018). ADHD in children and young people: Prevalence, care pathways, and service provision. The Lancet Psychiatry, 5(2), 175–186. https://doi.org/10.1016/S2215-0366(17)30167-0
